farrerol has been researched along with Lung Adenocarcinoma in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cai, C; Guo, Y; Li, Q; Xia, R | 1 |
1 other study(ies) available for farrerol and Lung Adenocarcinoma
| Article | Year |
|---|---|
Farrerol exhibits inhibitory effects on lung adenocarcinoma cells by activating the mitochondrial apoptotic pathway.
Topics: Adenocarcinoma of Lung; Animals; Apoptosis; Caspase 3; Caspase 9; Cell Line, Tumor; Cell Proliferation; Chromones; Humans; Lung Neoplasms; Mice; Proto-Oncogene Proteins c-bcl-2; Reactive Oxygen Species | 2022 |